Opinion: Reining in drug patents isn’t a silver bullet against high drug prices
One of the top orders of business for the Biden administration is curbing drug prices.
It’s a laudable goal. High drug prices are a major public health concern; there is broad political support for reining in the cost of drugs; and Americans pay a lot for drugs.
